Untargeted breathomics identifies metabolic signatures of immune activity, intestinal integrity, and fatigue in systemic lupus erythematosus

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Systemic Lupus Erythematosus

CD72 downregulation on DN2 B cells associates with disease activity and resistance to rituximab in systemic lupus erythematosus

Rheumatology (Oxford)

Wangriatisak K, Huang W, Sechi G, Oke V, Chemin K, Grönwall C, Gunnarsson I, Malmström V, Faustini F

doi: 10.1093/rheumatology/keag097

Systemic Lupus Erythematosus

Physical activity in relation to the risk of systemic lupus erythematosus: A prospective study including 401,745 individuals

Rheumatology (Oxford)

Xu B, Ruan P, Wu H, Gao Y, Long H, Wu IXY, Lu Q

doi: 10.1093/rheumatology/keaf150

Systemic Lupus Erythematosus

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus

Ann Rheum Dis

Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber-Bouyer R, Hagen M, Bergmann C, Wirsching A, Bozec A, PRECISESADS Clinical Consortium, Schneider M, Barturen G, Bertsias G, Boumpas DT, Alarcón-Riquelme ME, Mackensen A, Schett G, Parodis I

doi: 10.1016/j.ard.2025.06.2132

Systemic Lupus Erythematosus

Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in Brazilian SLE patients

Rheumatology (Oxford)

Mata-Machado CM, Lanna CCD, Garrido JC, Monticielo OA, Klumb EM, Tres GL, Moura FM, Telles RW

doi: 10.1093/rheumatology/keaf366

Systemic Lupus Erythematosus

Upper limb function impairment is independently associated with all Lupus Quality of Life (LupusQoL) domains in systemic lupus erythematosus

Rheumatology (Oxford)

Arkoumanis I, Pappa M, Keramiotou K, Sfikakis PP, Tektonidou MG

doi: 10.1093/rheumatology/keag025

Systemic Lupus Erythematosus

Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus

Rheumatology (Oxford)

Onishi A, Tsuji H, Sasai T, Shirakashi M, Hiwa R, Nakabo S, Akizuki S, Nakashima R, Nishimura K, Sada KE, Miyawaki Y, Umeda M, Yoshimi R, Ohno S, Yajima N, Kajiyama H, Sato S, Kishida D, Fujiwara M, Kida T, Matsuo Y, Takatani A, Onishi T, Ida T, Umekita K, Miyake H, Nakano H, Ikeda K, Ichinose K, Yoshifuji H, Tanaka M, Morinobu A

doi: 10.1093/rheumatology/keag080

Systemic Lupus Erythematosus

A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus

N Engl J Med

van Vollenhoven RF, Wang L, Merrill JT, Liu Y, Bao C, Li F, Hu J, Huang C, Zhao J, Huang C, Mo H, Wei W, Lu F, Li J, Zhao D, Wang W, Li L, Zuraw Q, Wang X, Wang X, Fang J, Zhang F, 18C010 Trial Investigators

doi: 10.1056/NEJMoa2414719

Systemic Lupus Erythematosus

Polypharmacy in Adults with Systemic Lupus Erythematosus

Arthritis Care Res (Hoboken)

Yang J, Growdon ME, Fitzpatrick J, Dunlop-Thomas C, Hoge C, Covinsky KE, Bowling CB, Lim SS, Yazdany J, Plantinga LC

doi: 10.1002/acr.25686

Related content

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

CD72 downregulation on DN2 B cells associates with disease activity and resistance to rituximab in systemic lupus erythematosus

Physical activity in relation to the risk of systemic lupus erythematosus: A prospective study including 401,745 individuals

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus

Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in Brazilian SLE patients

Upper limb function impairment is independently associated with all Lupus Quality of Life (LupusQoL) domains in systemic lupus erythematosus

Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus

A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus

Polypharmacy in Adults with Systemic Lupus Erythematosus